SARS‐CoV‐2 targets neurons of 3D human brain organoids
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
COVID-19 pandemic caused by SARS-CoV-2 infection is a public health emergency. COVID-19 typically exhibits respiratory illness. Unexpectedly, emerging clinical reports indicate that neurological symptoms continue to rise, suggesting detrimental effects of SARS-CoV-2 on the central nervous system (CNS). Here, we show that a Düsseldorf isolate of SARS-CoV-2 enters 3D human brain organoids within 2 days of exposure. We identified that SARS-CoV-2 preferably targets neurons of brain organoids. Imaging neurons of organoids reveal that SARS-CoV-2 exposure is associated with altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death. Our studies, therefore, provide initial insights into the potential neurotoxic effect of SARS-CoV-2 and emphasize that brain organoids could model CNS pathologies of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, organoids can be cultivated over months and probably even years, thus enabling the investigation of tissue maturation in a disease context as shown for SARS-CoV-2 infections in brain organoids87”
From Human disease models in drug development (2023) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SARS-CoV-2 tropism for neurons87 and cortical astrocytes88 or its preference for mature cell types and distinct neurotoxic effects were demonstrated in brain organoids.”
From Human disease models in drug development (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 7×
“ACE-2 is an entry receptor for SARS-CoV and efficient replication of SARS-CoV (SARS outbreak in the year 2003) and also depends on the expression level of ACE-2 (Li et al , 2003; Hoffmann et al , 2020).”
InfluentialCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 2×
“We adapted previously described protocol to differentiate iPSCs into brain organoids described earlier (Lancaster et al , 2013; Gabriel et al , 2016).”
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 1×
“However, emerging case reports showed that patients infected with SARS-CoV-2 suffered a sudden and complete loss of the olfactory function, stroke, and other severe neurological symptoms (Chen et al , 2020; Helms et al , 2020; Poyiadji et al , 2020; Sedaghat & Karimi, 2020; Virani et al , 2020).”
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931 · cited 1×
“Cortical neurons are positioned basally to the VZ, forming a cortical plate ) (Lancaster & Knoblich, 2014; Giandomenico & Lancaster, 2017; Gopalakrishnan, 2019).”
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Research works printed but not linked: 1
- Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW (2015) Principles of virology. Washington, DC: ASM Press
Cited by
Items 201–300 of 524
When stem cells meet COVID-19: recent advances, challenges and future perspectives
Li, S., Zhu, H., Zhao, M., Liu, W., Wang, L., Zhu, B., Xie, W. J., Zhao, C., Zhou, Y., Ren, C., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02683-1 · Cited by 22
“used iPSC-derived human brain organoids to establish a test system for SARS-CoV-2 infection, which provides an indication of the potential neurotoxic effects of SARS-CoV-2 [111].”
MethodOrganoid Models of SARS-CoV-2 Infection: What Have We Learned about COVID-19?
Tran, B. M., Deliyannis, G., Hachani, A., Earnest, L., Torresi, J., & Vincan, E. (2022) · Organoids · doi:10.3390/organoids1010002 · Cited by 22
Spanos, M., Shachar, S., Sweeney, T., Lehmann, H. I., Gokulnath, P., Li, G., Sigal, G. B., Nagaraj, R., Bathala, P., Rana, F., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104833 · Cited by 24
“Ofnote,thedirect neuroinvasiveness and neurotropism of SARS-CoV-2 has now been shown in animal experiments and CNS or-ganoids,whereSARS-CoV-2infectionwasshowntohavedetrimentaleffectstobothinfectedandneighboring neurons(Ramani et al., 2020; Zhang et al., 2020; Kumari et al., 2021; Songet al., 2021).”
Topologically-protected interior for three-dimensional confluent cellular collectives
Zhang, T., & Schwarz, J. M. (2022) · Physical Review Research · doi:10.1103/physrevresearch.4.043148 · Cited by 21
Katahira, J., Ohmae, T., Yasugi, M., Sasaki, R., Itoh, Y., Kohda, T., Hieda, M., Hirai, M. Y., Okamoto, T., & Miyamoto, Y. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad483 · Cited by 22
Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2023) · BMC Biology · doi:10.1186/s12915-023-01711-1 · Cited by 24
Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research
Premeaux, T. A., Mediouni, S., Léda, A. R., O’Brien, R. L. F., Valente, S. T., Fine, H. A., Nixon, D. F., & Ndhlovu, L. C. (2021) · mBio · doi:10.1128/mbio.00680-21 · Cited by 23
“rons (131, 133); however, another study showed that the choroid plexuses are primarily infected, with only large amounts of virus leading to neuronal and glial infec-”
BackgroundResultMicrofabricated disk technology: Rapid scale up in midbrain organoid generation
Mohamed, N., Lépine, P., Lacalle‐Aurioles, M., Sirois, J., Mathur, M., Reintsch, W., Beitel, L. K., Fon, E. A., & Durcan, T. M. (2021) · Methods · doi:10.1016/j.ymeth.2021.07.008 · Cited by 27
Neuroimmune multi-hit perspective of coronaviral infection
Hayley, S. P., & Sun, H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02282-0 · Cited by 21
Neuropathogenesis of acute coronavirus disease 2019
Farhadian, S., Seilhean, D., & Spudich, S. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000944 · Cited by 22
Ciolac, D., Racila, R., Duarte, C. L., Vasilieva, M., Diana, M., Nadejda, G., Condrea, A., Igor, C., Eremei, Z., Efremova, D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111730 · Cited by 20
“The exposure of neurons to SARS-CoV-2 results in neuronal death due to the abnormal intracellular distribution of tau proteins and hyperphosphorylation, as demonstrated in 3D models of human brain organoids [31].”
BackgroundZlacká, J., Stebelová, K., Zeman, M., & Herichová, I. (2021) · Physiological Research · doi:10.33549/physiolres.934754 · Cited by 23
Cárdenas, G., Fragoso, G., & Sciutto, E. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.12.008 · Cited by 22
Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
Latorre, D. (2022) · European Journal of Immunology · doi:10.1002/eji.202149475 · Cited by 20
Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
Karami, Z., Moradi, S., Eidi, A., Soleimani, M., & Jafarian, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1050856 · Cited by 30
“Human brain organoids Human-induced pluripotent stem cells (Ramani et al., 2020)”
BackgroundLennol, M. P., Ashton, N. J., Moreno, Ó., García‐Ayllón, M., Ramos, J. M., Andrés, M., León‐Ramírez, J., Boix, V., Gil, J., Blennow, K., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032715 · Cited by 24
“Furthermore, we assessed whether the levels of circulating angiotensin-converting enzyme 2 (ACE2) species, the host receptor of SARS-CoV-2, showed any changes in COVID-19 patients.”
BackgroundInfluentialGeneration of iPSC-derived human forebrain organoids assembling bilateral eye primordia
Gabriel, E., Albanna, W., Pasquini, G., Ramani, A., Josipović, N., Mariappan, A., Riparbelli, M. G., Callaini, G., Karch, C. M. M., Goureau, O., et al. (2023) · Nature Protocols · doi:10.1038/s41596-023-00814-x · Cited by 21
Self-citationNeuroinflammation in Post COVID‐19 Sequelae: Neuroinvasion and Neuroimmune Crosstalk
Reis, R. S. D., Selvam, S., & Ayyavoo, V. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.70009 · Cited by 24
SARS-CoV-2 S1 Protein Induces Endolysosome Dysfunction and Neuritic Dystrophy
Datta, G., Miller, N., Halcrow, P. W., Khan, N., Colwell, T., Geiger, J. D., & Chen, X. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.777738 · Cited by 22
Dedoni, S., Avdoshina, V., Camoglio, C., Siddi, C., Fratta, W., Scherma, M., & Fadda, P. (2022) · Molecules · doi:10.3390/molecules27134142 · Cited by 20
Applications and research trends in organoid based infectious disease models
Ryu, J.-O., Seong, Y.-J., Lee, E., Lee, S., & Lee, D. W. (2025) · Scientific Reports · doi:10.1038/s41598-025-07816-7 · Cited by 25
“Brain organoids have also been used to model infections beyond ZIKV, such as SARS-CoV-2-induced neuronal damage and tauopathy, and HIV-related neuroinflammation via infected microglia 39,43 .”
Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration
Gavilán, E., Medina-Guzman, R., Bahatyrevich-Kharitonik, B., & Ruano, D. (2024) · Cells · doi:10.3390/cells13020123 · Cited by 21
de Melo, I. S., Silva, R. S., Cunha, T. M., Goulart, L. R., Reis, W. L., Jardim, A. C. G., Shetty, A. K., & de Castro, O. W. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.008 · Cited by 22
Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms
Kase, Y., & Okano, H. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00165-8 · Cited by 20
“SARS-CoV-2 is more likely to infect neurons than neural progenitor cells (NPCs), causing changes in tau distribution, hyperphosphorylation of tau in infected neurons, and neuronal death [35].”
BackgroundEberle, R. J., Gering, I., Tusche, M., Ostermann, P. N., Müller, L., Adams, O., Schaal, H., Olivier, D. S., do Amaral, M. S., Arni, R. K., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15050540 · Cited by 18
Self-citationOrganoids and organ-on-chip technology for investigating host-microorganism interactions
Walocha, R., Kim, M., Wong-Ng, J., Gobaa, S., & Sauvonnet, N. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105319 · Cited by 21
Qi, X., Yuan, S., Ding, J., Sun, W., Shi, Y., Xing, Y., Liu, Z., Yao, Y., Fu, S., Sun, B., et al. (2024) · Aging Cell · doi:10.1111/acel.14352 · Cited by 21
Harness Organoid Models for Virological Studies in Animals: A Cross-Species Perspective
Sang, Y., Miller, L. C., Nelli, R. K., & Gimenez-Lirola, L. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.725074 · Cited by 18
Three-Dimensional Cell Culture Models to Study Respiratory Virus Infections Including COVID-19
Harb, A., Fakhreddine, M., Zaraket, H., & Saleh, F. (2021) · Biomimetics · doi:10.3390/biomimetics7010003 · Cited by 22
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Vanhulle, E., Stroobants, J., Provinciael, B., Camps, A., Noppen, S., Maes, P., & Vermeire, K. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105342 · Cited by 18
“Different groups have shown that human neural progenitor 420 cells, grown either as brain organoids or as neurospheres, are permissive to SARS421 CoV-2 infection (30, 35-38).”
BackgroundUtility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications
Weth, F. R., Peng, L., Paterson, E., Tan, S. T., & Gray, C. (2022) · Cells · doi:10.3390/cells12010153 · Cited by 25
“, surprisingly observed microglial cells and astrocytes in their organoids [62].”
BackgroundTau protein aggregation associated with SARS-CoV-2 main protease
Eberle, R. J., Coronado, M. A., Gering, I., Sommerhage, S., Korostov, K., Stefanski, A., Stühler, K., Kraemer‐Schulien, V., Blömeke, L., Bannach, O., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288138 · Cited by 19
“2020 showed that SARS-CoV-2 targets neurons of 3D human brain organoids and neurons invaded with SARS-CoV-2 at the cortical area display altered tau, tau hyperphosphorylation distribution and apparent neuronal death [33].”
BackgroundCOVID‐19 and the impact on Alzheimer's disease pathology
Furman, S., Green, K. N., & Lane, T. E. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15985 · Cited by 24
“Hyperphosphorylation and altered distribution of tau has been observed in in vitro organ-oid models infected with SARS-CoV-2 (Ramani et al., 2020 ).”
Amadoro, G., Latina, V., Stigliano, E., & Micera, A. (2023) · Cells · doi:10.3390/cells12222601 · Cited by 22
“…an aberrant subcellular redistribution of tau from axonal processes to soma, hyperphosphorylation at Threonine 231 (Thr231), apoptotic caspase-3 activation and, eventually, neuronal death, specific cellular changes that are reminiscent of key features associated with AD neuropathology [199].”
BackgroundThe nervous system during COVID ‐19: Caught in the crossfire
Natale, N. R., Lukens, J. R., & Petri, W. A. (2022) · Immunological Reviews · doi:10.1111/imr.13114 · Cited by 22
“Despite their efforts, each lab’s conclusion contradicts the next 197–199 , and it is most likely that SARS-CoV-2 tropism is extremely low in cells residing in the parenchyma 197,200,201 .”
Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected
Ferrara, F., Zovi, A., Masi, M., Langella, R., Trama, U., Boccellino, M., & Vitiello, A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02417-5 · Cited by 23
Human brain microphysiological systems in the study of neuroinfectious disorders
Barreras, P., Pamies, D., Härtung, T., & Pardo, C. A. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114409 · Cited by 20
Gugliandolo, A., Chiricosta, L., Calcaterra, V., Biasin, M., Cappelletti, G., Carelli, S., Zuccotti, G., Avanzini, M. A., Bramanti, P., Pelizzo, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158059 · Cited by 17
“found that SARS-CoV-2 targeted neurons of 3D human brain organoids but it did not appear to efficiently replicate [42].”
BackgroundWilliams, A., Branscome, H., Khatkar, P., Mensah, G. A., Sharif, S. A., Pinto, D. O., DeMarino, C., & Kashanchi, F. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00998-6 · Cited by 16
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
Vlieger, L. D., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103340 · Cited by 17
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection
Danta, C. C. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00335 · Cited by 16
Giani, A. M., & Chen, S. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102207 · Cited by 17
SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids
Trevisan, M., Riccetti, S., Sinigaglia, A., & Barzon, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052356 · Cited by 17
“Infection and replication of SARS-CoV-2, leading to reduced cell viability, has been reported in NPCs [115], while other researchers reported no infection or replication in the same cell types [118,119].”
InfluentialWerner, J., Kronberg, R. M., Stachura, P., Ostermann, P. N., Müller, L., Schaal, H., Bhatia, S., Kather, J. N., Borkhardt, A., Pandyra, A. A., et al. (2021) · Viruses · doi:10.3390/v13040610 · Cited by 16
Self-citationGao, C., Li, M., Deng, W., Ma, C., Chen, Y., Sun, Y., Du, T., Liu, Q.-L., Li, W., Zhang, B., et al. (2022) · Protein & Cell · doi:10.1007/s13238-022-00915-5 · Cited by 17
“However, several studies have demonstrated the presence of SARS-CoV-2 viral RNA in the brain organoids (Ramani et al., 2020; Zhang et al., 2020a) and brain tissue of COVID19 patients (Puelles et al., 2020; Song et al., 2021), and the virus could cross the blood-brain barrier (BBB) in a…”
BackgroundWatashi, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.094 · Cited by 17
Experimental Models to Study COVID-19 Effect in Stem Cells
Chugh, R. M., Bhanja, P., Norris, A. J., & Saha, S. (2021) · Cells · doi:10.3390/cells10010091 · Cited by 16
The impact of antidepressants on human neurodevelopment: Brain organoids as experimental tools
Marinho, L. S. R., Chiarantin, G. M. D., Ikebara, J. M., Cardoso, D. S., de Lima-Vasconcellos, T. H., Higa, G. S. V., Ferraz, M. S. A., Pasquale, R. D., Takada, S. H., Papes, F., et al. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.007 · Cited by 36
Efficient Gene Expression in Human Stem Cell Derived-Cortical Organoids Using Adeno Associated Virus
Cho, A., Bright, F., Morey, N., Au, C. G., Ittner, L. M., & Ke, Y. D. (2022) · Cells · doi:10.3390/cells11203194 · Cited by 17
Nishide, G., Lim, K., Tamura, M., Kobayashi, A., Zhao, Q., Hazawa, M., Ando, T., Nishida, N., & Wong, R. W.-C. (2023) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.3c01440 · Cited by 15
Human brain organoid: trends, evolution, and remaining challenges
Li, M., Yuan, Y., Hou, Z., Hao, S., Jin, L., & Wang, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390972 · Cited by 18
Impact of age and sex on neuroinflammation following SARS-CoV-2 infection in a murine model
Krishna, V. D., Chang, A., Korthas, H. T., Var, S. R., Seelig, D. M., Low, W. C., Li, L., & Cheeran, M. C. ‐. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1404312 · Cited by 15
“Several in vitro studies showed that the cells of the CNS, particularly astrocytes and neurons, support SARS-CoV-2 replication (Bullen et al., 2020; Jacob et al., 2020; Ramani et al., 2020; Wang et al., 2021; Andrews et al., 2022; Crunfli et al., 2022; Roczkowsky et al., 2023).”
FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease
Vavougios, G. D., Breza, M., Mavridis, T., & Krogfelt, K. A. (2021) · Brain Disorders · doi:10.1016/j.dscb.2021.100022 · Cited by 17
Fard, S. N., Petrone, L., Petruccioli, E., Alonzi, T., Matusali, G., Colavita, F., Castilletti, C., Capobianchi, M. R., & Goletti, D. (2021) · BioMed Research International · doi:10.1155/2021/8856018 · Cited by 16
SARS-CoV-2 infects brain choroid plexus and disrupts the blood-CSF-barrierPreprint
Pellegrini, L., Albecka, A., Mallery, D. L., Kellner, M. J., Paul, D., Carter, A. P., James, L. C., & Lancaster, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.20.259937 · Cited by 15
Ma, S., Zhao, H., & Galan, E. A. (2021) · Advanced Biology · doi:10.1002/adbi.202100535 · Cited by 16
Putative role of mitochondria in SARS-CoV-2 mediated brain dysfunctions: a prospect
Maurya, S. K., Baghel, M. S., Gaurav, G., Chaudhary, V., Kaushik, A. K., & Gautam, A. (2022) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2022.2108998 · Cited by 14
“In neurons, it is associated with tau abnormalities, i.e. altered distribution of tau from axon to soma and hyper-phosphorylation leading to neuronal cell death (Ramani et al., 2020).”
3D engineered tissue models for studying human-specific infectious viral diseases
Hwang, K. S., Seo, E. U., Choi, N., Kim, J., & Kim, H. N. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.09.010 · Cited by 21
“cultured iPSC-derived human brain organoids for 60 days and then exposed them to coronavirus [168].”
MethodLowered Delta Activity in Post-COVID-19 Patients with Fatigue and Cognitive Impairment
Ortelli, P., Quercia, A., Cerasa, A., Dezi, S., Ferrazzoli, D., Sebastianelli, L., Saltuari, L. L., Versace, V., & Quartarone, A. (2023) · Biomedicines · doi:10.3390/biomedicines11082228 · Cited by 18
“GABAergic neurons are known to have a high expression of ACE2 receptors [37,38], known to be SARS-CoV-2 targets [12,39].”
BackgroundLaudański, K., Hajj, J., Restrepo, M., Siddiq, K., Okeke, T., & Rader, D. J. (2021) · Biomedicines · doi:10.3390/biomedicines9121791 · Cited by 16
“Moreover, SARS-CoV-2 co-localizes with the phosphorylated tau (τ) protein, triggering neuronal death or interfering with the distribution of τ [21].”
BackgroundEmerging neurotropic features of SARS-CoV-2
Zhan, W.-R., Huang, J., Zeng, P.-M., Tian, W.-Y., & Luo, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab044 · Cited by 14
“Some studies showed that SARS-CoV-2 preferably targets mature neurons (Ramani et al., 2020; Song et al., 2021), whereas other studies state that SARS-CoV-2 cannot target neuronal cell types (Pellegrini et al.”
InfluentialRahmani, B., Ghashghaei, E., Zendehdel, M., Baghbanzadeh, A., & Khodadadi, M. (2022) · Physiology International · doi:10.1556/2060.2022.00019 · Cited by 13
Conjunctival epithelial cells resist productive SARS-CoV-2 infection
Jackson, R. M., Hatton, C. F., Spegarova, J. S., Γεωργίου, Μ., Collin, J., Stephenson, E., Verdon, B., Haq, I., Hussain, R., Coxhead, J., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.017 · Cited by 13
Li, C., Song, W., Chan, J. F., Chen, Y., Liu, F., Ye, Z., Lam, A. H.-C., Cai, J., Lee, A. C.-Y., Wong, B. H., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2207678 · Cited by 13
Kikinis, Z., Castañeyra-Perdomo, A., González–Mora, J. L., Rushmore, J., Toppa, P. H., Haggerty, K., Papadimitriou, G., Rathi, Y., Kubicki, M. R., Kikinis, R., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1337888 · Cited by 13
“…using brain organoids, SARS-CoV-2 virus affects neurons showing altered distribution of tau throughout the neurons from axons to soma, hyper-phosphorylation and neuronal death, it remains unclear whether these effects are produced directly by the virus or other factors such as neuronal stress (78).”
BackgroundOrganoids and chimeras: the hopeful fusion transforming traumatic brain injury research
Bellotti, C., Samudyata, S., Thams, S., Sellgren, C., & Rostami, E. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01845-5 · Cited by 11
“Indeed, COs have been used to study a variety of brain disorders in vitro [2, 109, 131], including microcephaly [59], autism [61, 69], Alzheimer [62, 83], Zika virus [56, 82] and Sars-CoV-2 infection [43, 79, 84, 89].”
BackgroundCOVID-19: Auswirkungen auf das zentrale und periphere Nervensystem
„CNS-COVID19“, D.-T., Ritschel, N., COVID-19“, „. P. –. N. R. B., Radbruch, H., Herden, C., Schneider, N., Dittmayer, C., Franz, J., Thomas, C., Boos, G. S., et al. (2021) · Der Pathologe · doi:10.1007/s00292-021-00924-x · Cited by 15
“Hingegen sind neuronale Kulturen, Neurosphären und 3D-GehirnOrganoide aus induzierten pluripotenten humanen Stammzellen gut geeignet, um die Effekte einer SARS-CoV-2-Infektion auf Zellen des ZNS in vitro zu untersuchen [6, 8, 27, 43, 46, 52].”
BackgroundCerebral organoids and their potential for studies of brain diseases in domestic animals
Pain, B., Baquerre, C., & Coulpier, M. (2021) · Veterinary Research · doi:10.1186/s13567-021-00931-z · Cited by 16
Biomaterials-based strategies for in vitro neural models
Özgün, A., Lomboni, D. J., Arnott, H. G., Staines, W. A., Woulfe, J., & Variola, F. (2022) · Biomaterials Science · doi:10.1039/d1bm01361k · Cited by 16
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19
Şirin, S., Dolanbay, S. N., & Aslım, B. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02499-0 · Cited by 14
3D Bioprinted Neural‐Like Tissue as a Platform to Study Neurotropism of Mouse‐Adapted SARS‐CoV‐2
de Melo, B. A. G., Mundim, M. V., Lemes, R. M. R., Cruz, E. M., Ribeiro, T. N., Santiago, C. F., da Fonsêca, J. H. L., Benincasa, J. C., Stilhano, R. S., Mantovani, N., et al. (2022) · Advanced Biology · doi:10.1002/adbi.202200002 · Cited by 14
Durand, D., Olivera, E., Sáez, A., Carniglia, L., Caruso, C. M., & Lasaga, M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.360273 · Cited by 14
Gubarev, Y. A., Lebedevа, N. S., Yurina, E. S., Syrbu, S. А., Kiselev, A. N., & Lebedev, M. A. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.08.003 · Cited by 13
Innate Receptors Expression by Lung Nociceptors: Impact on COVID-19 and Aging
Hiroki, C. H., Sarden, N., Hassanabad, M. F., & Yipp, B. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.785355 · Cited by 15
“The developments of models, such as hACE2 mice model (86) as well as organoids (87), has allowed a better understanding of the mechanisms through which SARSCoV-2 infects and mediates COVID-19 pathology, including in the airways innervation.”
MethodMesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment
Huang, Y., Li, X., & Yang, L. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03034-4 · Cited by 12
Crook, H., Ramírez, A., Hosseini, A. A., Vavougios, G. D., Lehmann, C., Bruchfeld, J., Schneider, A., d’Avossa, G., Re, V. L., Salmoiraghi, A., et al. (2023) · Brain Connectivity · doi:10.1089/brain.2022.0058 · Cited by 12
“Infection of three-dimensional brain organoids with SARS-CoV-2 triggers tau hyperphosphorylation, axonal to soma redistribution, and apoptosis (Ramani et al, 2021).”
SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro
Zilio, G., Masato, A., Sandre, M., Caregnato, A., Moret, F., Macioła, A. K., Antonini, A., Brucale, M., Cendron, L., Plotegher, N., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00468 · Cited by 12
A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2
Bedran, D., Bedran, G., & Kote, S. (2024) · Vaccines · doi:10.3390/vaccines12030222 · Cited by 18
“Shifts in Tau localization and hyperphosphorylation observed in SARS-CoV-2-infected neurons resemble early tauopathy hallmarks [39].”
BackgroundVavougios, G. D., Tseriotis, V., Liampas, A., Mavridis, T., de Erausquin, G. A., & Hadjigeorgiou, G. M. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2024.1352118 · Cited by 13
“This aspect of our model, previously predicting beta amyloidosis and tauopathy based on the IFN-I response secondary to SARS-CoV-2 infection (Ramani et al., 2020; Vavougios et al., 2021a,b, 2022a,b,c; Di Primio et al., 2023) has been independently validated (Ramani et al., 2020; Green et al., 2022;…”
BackgroundMethodResultInfluentialSARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids
Chau, C. W., To, A., Au-Yeung, R. K. H., Tang, K., Xiang, Y., Ruan, D., Zhang, L., Wong, H., Zhang, S., Au, M. T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59405-9 · Cited by 12
Catch me if you can: SARS-CoV-2 detection in brains of deceased patients with COVID-19
Frank, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30371-9 · Cited by 13
Egilmezer, E., & Rawlinson, W. D. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2227 · Cited by 11
“iPSC � SARS‐CoV‐2 NRW‐42 Brain organoids are permissive to infection but do not support active viral replication.(35)”
BackgroundA Peek into Pandora’s Box: COVID-19 and Neurodegeneration
Chandra, A., & Johri, A. (2022) · Brain Sciences · doi:10.3390/brainsci12020190 · Cited by 16
Zhang, X.-P., Wang, X., Wang, S.-N., & Miao, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369100 · Cited by 15
“For instance, hCOs exposed to severe acute respiratory syndrome coronavirus 2 have been applied to interrogate the infection mechanisms and neurotoxicity associated with the current global outbreak of corona virus disease 2019 (Ramani et al., 2020).”
BackgroundRetina stem cells, hopes and obstacles
German, O. L., Vallese-Maurizi, H., Soto, T. B., Rotstein, N. P., & Politi, L. E. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i10.1446 · Cited by 13
Organoids: physiologically relevant ex vivo models for viral disease research
Wang, Y., Peng, D., Li, M., Meng, Y., Li, T., Li, S., Qiu, H., & Li, L. (2025) · Journal of Virology · doi:10.1128/jvi.01132-25 · Cited by 12
Chronic Neuroplasticity Changes Following Neurotropic Viral Infection: Mechanisms and Implications
Mohabbat, A., & Baghi, H. B. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01622-5 · Cited by 12
“Besides inducing neuronal cell death, the spread of the Japanese encephalitis virus in astrocytes and microglia leads to an increase in pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-α), (interleukin) IL-6, and IL-1β.”
InfluentialRole of Tau protein in long COVID and potential therapeutic targets
Marwaha, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1280600 · Cited by 13
Choi, C., Gadhave, K., Villano, J., Pekosz, A. S., Mao, X., & Jia, H. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29349 · Cited by 14
“SARS ‐ CoV ‐ 2 infection has been documented to induce hyperphosphorylated tau (p ‐ tau) pathology in various models, encompassing human neuronal cell lines, 21 human neurons, 22 as well as in animal subjects such as Syrian golden hamsters, 23 K18 ‐ hACE2 and C57BL/6J mice.”
BackgroundGonzález-Sastre, R., Coronel, R., Bernabeu-Zornoza, A., Mateos-Martínez, P., Rosca, A., López-Alonso, V., & Liste, I. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314231226027 · Cited by 14
“11 Furthermore, hCOs generated from patient induced pluripotent stem cells (iPSCs) or from genome edited hPSCs, allow obtaining models for the study of neuropsychiatric and neurodegenerative diseases in addition to drug testing.”
BackgroundSulaksono, H. L. S., Annisa, A., Ruslami, R., Mufeeduzzaman, M., Panatarani, C., Hermawan, W., Ekawardhani, S., & Joni, I. M. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s455940 · Cited by 14
Defense of COVID-19 by Human Organoids
Lv, T., Meng, F., Yu, M., Huang, H., Lin, X., & Zhao, B. T. (2021) · Phenomics · doi:10.1007/s43657-021-00015-0 · Cited by 11
Sharma, S., Jagadeesh, H., Saxena, A., Chakravarthy, H., & Devanathan, V. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00232-9 · Cited by 12
“A SARS-CoV-2 isolate from Germany was demonstrated to infect neurons in 3D human brain organoids, and was associated with Tau abnormalities and neuronal cell death (Ramani et al. 2020).”
Carter, M., Casey, S., O’Keeffe, G. W., Gibson, L., Gallagher, L., & Murray, D. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.823096 · Cited by 18
Engineering cerebral folding in brain organoids
Huang, Y., & Scott, G. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335789 · Cited by 11
Cárdenas, G., Chávez‐Canales, M., Espinosa-García, A. M., Jordán‐Ríos, A., Malagon, D. A., Murillo, M. F. M., Torres-Araujo, L. V., Barajas‐Campos, R. L., Wong‐Chew, R. M., González, L. E. R., et al. (2022) · Trials · doi:10.1186/s13063-022-06075-5 · Cited by 16
Flores‐León, M., Lázaro, D. F., Shvachiy, L., Kriško, A., & Outeiro, T. F. (2021) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2021.140693 · Cited by 12
Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling
Csöbönyeiová, M., Klein, M., Kuniaková, M., Varga, I., & Danišovič, Ľ. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043459 · Cited by 10
“Brain organoids Heparin, Y27632, L 2-mercaptoethanol, insulin, and vitamin A Yes—only neurons Presence of aberrant Tau protein in SARS-CoV-2 + neurons [81]”
BackgroundLong COVID: From olfactory dysfunctions to viral Parkinsonism
Pandey, S., Bapat, V., Abraham, J. N., & Abraham, N. M. (2024) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1002/wjo2.175 · Cited by 11
“81,82 The neuroinvasive potential of SARS ‐ CoV ‐ 2 has also been investigated in mouse models by expressing the hACE2 receptor under the K18 promoter.”
Modeling infectious diseases of the central nervous system with human brain organoids
Priyathilaka, T. T., Laaker, C. J., Herbáth, M., Fábry, Z., & Sándor, M. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.013 · Cited by 13
Metadata
- Authors
- Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., & Gopalakrishnan, J.
- Affiliations
- Düsseldorf University Hospital (DE)
- Centre National de la Recherche Scientifique (FR)
- University of Cologne (DE)
- University Hospital Münster (DE)
- Corresponding author
- Schaal, Heiner
- Gopalakrishnan, Jay
- ORCID
- Ramani, Anand
- Müller, Lisa
- Ostermann, Philipp N
- Gabriel, Elke
- Müller‐Schiffmann, Andreas
- Mariappan, Aruljothi
- Goureau, Olivier
- Gruell, Henning
- Walker, Andreas
- Houwaart, Torsten
- Dilthey, Alexander
- Wohlgemuth, Kai
- Omran, Heymut
- Wieczorek, Dagmar
- Adams, Ortwin
- Timm, Jörg
- Korth, Carsten
- Schaal, Heiner
- Gopalakrishnan, Jay
- Venue
- The EMBO Journal
- Published
- 2020-09-23
- Volume
- 39
- Issue
- 20
- Pages
- e106230-e106230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7560208
- OpenAlex
- W3081536095
- Cited by
- 518
- References
- 63
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 71 · 2023: 85 · 2022: 126 · 2021: 145 · 2020: 36
- FWCI
- 42.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, other-oa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fritz Thyssen Stiftung (10.17.2.018MN)
- Juergen Manchot Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, brain organoids, neuronal infection, neurotoxicity, tau hyperphosphorylation, neuronal cell death, central nervous system pathology
- MeSH terms
- Betacoronavirus, SARS-CoV-2, Animals, Brain, Chlorocebus aethiops, Humans, Nervous System Diseases, Neurons, Organoids, Vero Cells, tau Proteins, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.